Physician
Kaiser Foundation Health Plan of the Northwest
Kaiser Foundation Health Plan of the Northwest was paid $116.27M by Medicaid between Jan 2018 and Dec 2024, across 419 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 22% of everything it billed.
33Billing provider infoKAISER FOUNDATION HEALTH PLAN OF THE NORTHWEST
PORTLAND, OR 97232
PORTLAND, OR 97232
33aNPI1184786527assigned 12/14/2006
33bProvider typePediatrics Physician
28Total paid$116.27M
24GClaims1,341,812
24DCodes billed419
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Oregon
Rank by total paid#1 of 87
Median peer was paid$147K
This provider vs. median790×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 177,026 | $10.95M | |
| 2019 | 268,942 | $18.26M | |
| 2020 | 119,175 | $9.27M | |
| 2021 | 171,282 | $14.31M | |
| 2022 | 194,974 | $18.33M | |
| 2023 | 205,441 | $21.96M | |
| 2024incomplete | 204,972 | $23.17M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 162,406 | 157,350 | $25.66M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 105,010 | 100,838 | $22.58M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.9% | 36,414 | 34,322 | $8.07M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.4% | 30,007 | 28,452 | $3.96M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3.2% | 12,771 | 12,587 | $3.77M |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.7% | 84,368 | 83,351 | $1.99M |
| 71046 | Radiologic examination, chest; 2 views | 1.7% | 41,953 | 40,239 | $1.95M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.5% | 4,166 | 4,001 | $1.76M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.2% | 9,393 | 8,391 | $1.38M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.1% | 5,001 | 4,972 | $1.23M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.0% | 5,613 | 5,437 | $1.22M |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 21,413 | 21,097 | $1.13M |
407 more codes
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14,810 | $1.09M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 14,809 | $1.09M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 3,843 | $1.09M |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 77,903 | $1.07M |
| 91320 | <1% | 6,157 | $1.05M | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 4,184 | $1.04M |
| 99442 | <1% | 11,988 | $928K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 7,695 | $905K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 7,820 | $863K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 3,593 | $844K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 5,658 | $786K |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 332 | $767K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 3,335 | $764K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 2,358 | $757K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 19,735 | $699K |
| 76830 | Ultrasound, transvaginal | <1% | 2,972 | $692K |
| 76801 | <1% | 2,825 | $689K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 6,309 | $671K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,626 | $646K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 13,232 | $609K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 32,383 | $605K |
| 88142 | <1% | 10,541 | $579K | |
| 80053 | Comprehensive metabolic panel | <1% | 21,890 | $561K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 555 | $555K |
| 90480 | <1% | 7,074 | $551K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 4,896 | $528K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 2,831 | $512K |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 2,046 | $460K |
| 92015 | Determination of refractive state | <1% | 16,825 | $438K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 6,143 | $434K |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | <1% | 1,507 | $420K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 4,327 | $407K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 15,828 | $405K |
| 95800 | <1% | 1,299 | $402K | |
| 73630 | <1% | 5,802 | $396K | |
| 99441 | <1% | 8,723 | $392K | |
| 71250 | <1% | 1,332 | $388K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 4,652 | $385K |
| 80061 | Lipid panel | <1% | 10,093 | $371K |
| 81507 | <1% | 1,763 | $363K | |
| 81025 | <1% | 17,652 | $349K | |
| 90686 | <1% | 42,930 | $320K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 698 | $317K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 2,980 | $291K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 2,847 | $290K |
| 86003 | <1% | 1,387 | $275K | |
| 87506 | <1% | 456 | $270K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13,013 | $262K |
| 76770 | <1% | 1,202 | $259K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 338 | $256K |
| 86780 | <1% | 6,566 | $250K | |
| 92134 | <1% | 5,174 | $241K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 448 | $238K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 829 | $235K |
| 85027 | <1% | 13,438 | $224K | |
| 99421 | <1% | 7,030 | $224K | |
| 73564 | <1% | 2,003 | $218K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 820 | $206K |
| 81001 | <1% | 27,197 | $201K | |
| 73610 | <1% | 2,783 | $194K | |
| 82728 | <1% | 5,407 | $172K | |
| 86803 | <1% | 4,140 | $170K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,382 | $169K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 746 | $164K |
| 64615 | <1% | 521 | $162K | |
| 88307 | <1% | 368 | $157K | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 3,015 | $156K |
| 0002A | <1% | 3,925 | $153K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 1,840 | $150K |
| 0001A | <1% | 4,047 | $149K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 2,373 | $144K |
| 11721 | <1% | 2,810 | $143K | |
| 82607 | <1% | 3,539 | $142K | |
| 87210 | <1% | 10,643 | $140K | |
| A7034 | Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap | <1% | 2,452 | $140K |
| 73030 | <1% | 2,100 | $138K | |
| 87340 | <1% | 4,588 | $137K | |
| 88141 | <1% | 2,056 | $134K | |
| 0124A | <1% | 3,490 | $132K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 885 | $132K |
| 71045 | Radiologic examination, chest; single view | <1% | 9,578 | $125K |
| 0054A | <1% | 3,145 | $124K | |
| 86481 | <1% | 3,530 | $123K | |
| 72100 | <1% | 1,440 | $123K | |
| 92227 | <1% | 4,077 | $122K | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 193 | $120K |
| 83993 | <1% | 2,178 | $119K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 595 | $116K |
| 84702 | <1% | 2,852 | $116K | |
| 0004A | <1% | 3,219 | $110K | |
| 76536 | <1% | 472 | $109K | |
| 0064A | <1% | 2,998 | $106K | |
| 99443 | <1% | 843 | $102K | |
| 88342 | <1% | 571 | $98K | |
| 74018 | <1% | 1,514 | $97K | |
| 73110 | <1% | 1,146 | $94K | |
| 73130 | <1% | 1,241 | $94K | |
| 83690 | <1% | 5,769 | $92K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 889 | $92K |
| 87529 | <1% | 461 | $92K | |
| 87653 | <1% | 903 | $89K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 78 | $89K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,120 | $87K |
| 87536 | <1% | 366 | $86K | |
| 0071A | <1% | 2,188 | $85K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 556 | $85K |
| 82565 | <1% | 6,535 | $83K | |
| 97161 | <1% | 316 | $78K | |
| 90656 | <1% | 3,572 | $76K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 160 | $74K |
| 0072A | <1% | 1,830 | $73K | |
| E0601 | Continuous positive airway pressure (cpap) device | <1% | 183 | $73K |
| 81003 | <1% | 13,134 | $73K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 430 | $71K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,003 | $67K |
| 87077 | <1% | 2,825 | $65K | |
| 84403 | <1% | 3,215 | $64K | |
| 83550 | <1% | 2,626 | $62K | |
| 87522 | Neg quan hep c or qual rna | <1% | 517 | $62K |
| A7035 | Headgear used with positive airway pressure device | <1% | 2,492 | $58K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 561 | $56K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 215 | $56K |
| 84460 | <1% | 3,910 | $55K | |
| 87808 | <1% | 1,790 | $54K | |
| 99460 | <1% | 294 | $53K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,527 | $53K |
| 95806 | <1% | 285 | $52K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 91 | $51K |
| 87186 | <1% | 2,188 | $51K | |
| 0011A | <1% | 1,516 | $49K | |
| 98968 | <1% | 574 | $49K | |
| 73502 | <1% | 588 | $48K | |
| 83516 | <1% | 1,468 | $48K | |
| 76642 | <1% | 333 | $47K | |
| 97802 | <1% | 231 | $46K | |
| 83540 | <1% | 2,638 | $46K | |
| 72081 | <1% | 783 | $45K | |
| 77080 | <1% | 645 | $43K | |
| 84153 | <1% | 885 | $43K | |
| 0012A | <1% | 1,188 | $43K | |
| A7030 | Full face mask used with positive airway pressure device, each | <1% | 564 | $42K |
| 73140 | <1% | 555 | $41K | |
| 85610 | <1% | 5,081 | $40K | |
| 82105 | <1% | 3,200 | $40K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 208 | $39K |
| 86140 | <1% | 2,718 | $38K | |
| 80076 | <1% | 1,696 | $38K | |
| E0562 | Humidifier, heated, used with positive airway pressure device | <1% | 269 | $38K |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | <1% | 96 | $38K |
| 87081 | <1% | 1,887 | $36K | |
| 84439 | <1% | 1,397 | $35K | |
| 87338 | <1% | 4,338 | $34K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 99 | $33K |
| 86787 | <1% | 892 | $33K | |
| 82042 | <1% | 2,234 | $32K | |
| 82670 | <1% | 383 | $31K | |
| 84146 | <1% | 551 | $30K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 205 | $30K |
| 73562 | <1% | 367 | $30K | |
| 97803 | <1% | 248 | $30K | |
| 86762 | <1% | 713 | $30K | |
| 82746 | <1% | 771 | $29K | |
| 99417 | Prolong home eval add 15m | <1% | 190 | $29K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 86 | $29K |
| 87070 | <1% | 1,189 | $28K | |
| 84132 | <1% | 2,574 | $28K | |
| 80069 | <1% | 1,490 | $28K | |
| 90662 | <1% | 1,152 | $28K | |
| 97165 | <1% | 118 | $27K | |
| 87517 | <1% | 306 | $27K | |
| 83001 | <1% | 500 | $26K | |
| 86706 | <1% | 849 | $26K | |
| 82570 | <1% | 2,108 | $24K | |
| 86704 | <1% | 673 | $22K | |
| 86255 | <1% | 232 | $21K | |
| 43235 | <1% | 74 | $21K | |
| 99188 | <1% | 721 | $21K | |
| 84450 | <1% | 1,462 | $20K | |
| 92567 | <1% | 588 | $20K | |
| 0052A | <1% | 514 | $20K | |
| 0134A | <1% | 556 | $20K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 13 | $20K |
| 98967 | <1% | 344 | $20K | |
| 88304 | <1% | 371 | $20K | |
| 90679 | <1% | 76 | $19K | |
| 0051A | <1% | 480 | $19K | |
| 82784 | <1% | 589 | $19K | |
| 96112 | <1% | 97 | $19K | |
| 88341 | <1% | 53 | $19K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 34 | $19K |
| 81050 | <1% | 1,932 | $18K | |
| 91319 | <1% | 460 | $18K | |
| 83735 | <1% | 1,156 | $18K | |
| 90670 | <1% | 3,324 | $18K | |
| A7037 | Tubing used with positive airway pressure device | <1% | 2,063 | $18K |
| 86038 | <1% | 513 | $18K | |
| A9279 | Monitoring feature/device, stand-alone or integrated, any type, includes all accessories, components and electronics, not otherwise classified | <1% | 267 | $18K |
| 83970 | <1% | 176 | $18K | |
| 86160 | <1% | 320 | $17K | |
| 96113 | <1% | 54 | $17K | |
| 72050 | <1% | 154 | $16K | |
| 86200 | <1% | 516 | $16K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 53 | $16K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 42 | $16K |
| 82247 | <1% | 1,292 | $15K | |
| 0003A | <1% | 433 | $15K | |
| 0154A | <1% | 399 | $15K | |
| 90962 | <1% | 82 | $15K | |
| 20610 | <1% | 106 | $15K | |
| 96417 | <1% | 95 | $15K | |
| 0031A | <1% | 382 | $15K | |
| 84550 | <1% | 1,199 | $14K | |
| 87205 | <1% | 1,145 | $14K | |
| 86696 | <1% | 283 | $14K | |
| 82248 | <1% | 1,017 | $13K | |
| 96415 | <1% | 141 | $13K | |
| 93971 | <1% | 167 | $13K | |
| 84165 | <1% | 343 | $13K | |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | <1% | 13 | $13K |
| 86708 | <1% | 378 | $13K | |
| 82550 | <1% | 740 | $13K | |
| 0502F | <1% | 1,957 | $12K | |
| 83520 | <1% | 340 | $12K | |
| 96160 | <1% | 1,529 | $12K | |
| 84402 | <1% | 2,471 | $12K | |
| 98966 | <1% | 371 | $12K | |
| A7033 | Pillow for use on nasal cannula type interface, replacement only, pair | <1% | 549 | $12K |
| 96040 | <1% | 79 | $12K | |
| 82951 | <1% | 382 | $12K | |
| 88112 | <1% | 132 | $12K | |
| 82950 | <1% | 806 | $11K | |
| 71271 | <1% | 25 | $11K | |
| 83498 | <1% | 742 | $10K | |
| 87505 | <1% | 25 | $10K | |
| 83655 | <1% | 2,133 | $10K | |
| 84630 | <1% | 1,445 | $10K | |
| 0074A | <1% | 242 | $10K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 143 | $10K |
| 83615 | <1% | 586 | $10K | |
| 86361 | <1% | 156 | $10K | |
| 86695 | <1% | 284 | $9K | |
| 82627 | <1% | 150 | $9K | |
| 73221 | <1% | 16 | $9K | |
| 86765 | <1% | 257 | $9K | |
| 59025 | Fetal non-stress test | <1% | 70 | $9K |
| 86431 | <1% | 558 | $9K | |
| A7038 | Filter, disposable, used with positive airway pressure device | <1% | 2,368 | $9K |
| 87329 | <1% | 253 | $8K | |
| 84480 | <1% | 204 | $8K | |
| 86592 | <1% | 657 | $8K | |
| 82040 | <1% | 634 | $8K | |
| 0081A | <1% | 194 | $8K | |
| 84075 | <1% | 552 | $8K | |
| 87040 | <1% | 181 | $8K | |
| 81329 | <1% | 15 | $8K | |
| 88344 | <1% | 20 | $8K | |
| 83002 | <1% | 145 | $7K | |
| 0053A | <1% | 189 | $7K | |
| 81002 | <1% | 936 | $7K | |
| 91318 | <1% | 214 | $7K | |
| 82103 | <1% | 1,013 | $7K | |
| 0111A | <1% | 166 | $7K | |
| 84432 | <1% | 120 | $7K | |
| 86709 | <1% | 204 | $6K | |
| 84425 | <1% | 652 | $6K | |
| 96367 | <1% | 91 | $6K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 40 | $6K |
| 92523 | <1% | 12 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 239 | $6K |
| 98970 | <1% | 244 | $6K | |
| 99205 | Prolong outpt/office vis | <1% | 12 | $6K |
| 84100 | <1% | 516 | $6K | |
| A4604 | Tubing with integrated heating element for use with positive airway pressure device | <1% | 223 | $6K |
| 85652 | <1% | 778 | $6K | |
| 97166 | <1% | 25 | $6K | |
| 0073A | <1% | 138 | $6K | |
| 88312 | <1% | 38 | $5K | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 315 | $5K |
| 0082A | <1% | 132 | $5K | |
| 82533 | <1% | 118 | $5K | |
| 96411 | <1% | 30 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 187 | $5K |
| 82310 | <1% | 403 | $5K | |
| 95819 | <1% | 15 | $5K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 336 | $5K |
| 0112A | <1% | 117 | $5K | |
| 72110 | <1% | 38 | $5K | |
| 82977 | <1% | 220 | $4K | |
| 84295 | <1% | 366 | $4K | |
| 86735 | <1% | 112 | $4K | |
| 96158 | <1% | 42 | $4K | |
| 82525 | <1% | 509 | $4K | |
| 0034A | <1% | 124 | $4K | |
| 86480 | <1% | 105 | $4K | |
| 95886 | <1% | 14 | $4K | |
| 87209 | <1% | 438 | $4K | |
| 92060 | <1% | 29 | $4K | |
| A9609 | Fludeoxyglucose f18 up to 15 millicuries | <1% | 38 | $4K |
| 87101 | <1% | 171 | $4K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 48 | $4K |
| 64405 | <1% | 15 | $3K | |
| 92002 | <1% | 27 | $3K | |
| 82947 | <1% | 304 | $3K | |
| 73090 | <1% | 63 | $3K | |
| 77072 | <1% | 53 | $3K | |
| 95908 | <1% | 12 | $3K | |
| 84156 | <1% | 349 | $3K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 43 | $3K |
| 87324 | <1% | 102 | $3K | |
| 87449 | <1% | 100 | $3K | |
| 87177 | <1% | 437 | $3K | |
| 92557 | <1% | 40 | $3K | |
| 76886 | <1% | 12 | $3K | |
| 90474 | <1% | 117 | $3K | |
| G0008 | Administration of influenza virus vaccine | <1% | 1,566 | $3K |
| 92504 | <1% | 37 | $3K | |
| 90698 | <1% | 1,169 | $3K | |
| J7999 | Compounded drug, not otherwise classified | <1% | 38 | $3K |
| 87563 | <1% | 26 | $3K | |
| 84244 | <1% | 212 | $3K | |
| 87075 | <1% | 97 | $3K | |
| 86308 | <1% | 203 | $2K | |
| 85014 | <1% | 461 | $2K | |
| A7039 | Filter, non disposable, used with positive airway pressure device | <1% | 1,378 | $2K |
| 85018 | <1% | 455 | $2K | |
| 97162 | <1% | 12 | $2K | |
| 72072 | <1% | 24 | $2K | |
| 80178 | <1% | 121 | $2K | |
| 72070 | <1% | 27 | $2K | |
| 82340 | <1% | 132 | $2K | |
| 83883 | <1% | 37 | $2K | |
| 84512 | <1% | 83 | $2K | |
| 11056 | <1% | 14 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 35 | $2K |
| 90961 | <1% | 31 | $2K | |
| 80047 | <1% | 61 | $2K | |
| 85730 | <1% | 117 | $2K | |
| 90677 | <1% | 367 | $2K | |
| 99310 | Prolong nursin fac eval 15m | <1% | 29 | $2K |
| 86376 | <1% | 41 | $2K | |
| 99422 | <1% | 25 | $2K | |
| 83021 | <1% | 29 | $2K | |
| 69210 | <1% | 12 | $2K | |
| 0013A | <1% | 45 | $1K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 14 | $1K |
| 86665 | <1% | 15 | $1K | |
| 85390 | <1% | 13 | $1K | |
| 82390 | <1% | 41 | $1K | |
| 84520 | <1% | 127 | $1K | |
| 87593 | <1% | 17 | $1K | |
| 73560 | <1% | 14 | $1K | |
| 76882 | <1% | 13 | $1K | |
| 99201 | <1% | 14 | $1K | |
| 94010 | <1% | 44 | $1K | |
| 73100 | <1% | 15 | $1K | |
| 82088 | <1% | 126 | $1K | |
| 85007 | <1% | 118 | $1K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 23 | $978.59 |
| 73070 | <1% | 14 | $847.00 | |
| 85045 | <1% | 89 | $828.00 | |
| 84446 | <1% | 166 | $823.20 | |
| 84255 | <1% | 56 | $733.60 | |
| 82397 | <1% | 12 | $732.20 | |
| 84590 | <1% | 149 | $672.00 | |
| 90715 | <1% | 12 | $648.00 | |
| 90648 | <1% | 708 | $638.00 | |
| 72170 | <1% | 12 | $623.00 | |
| 86664 | <1% | 13 | $598.00 | |
| 92587 | <1% | 12 | $585.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 155 | $582.17 |
| 90744 | <1% | 297 | $581.09 | |
| 86800 | <1% | 102 | $542.28 | |
| 86663 | <1% | 13 | $507.00 | |
| 82435 | <1% | 34 | $462.00 | |
| 86812 | <1% | 24 | $440.00 | |
| 80164 | <1% | 13 | $440.00 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 12 | $429.44 |
| 51798 | <1% | 14 | $394.00 | |
| 96152 | <1% | 75 | $359.10 | |
| 82952 | <1% | 29 | $348.00 | |
| 99499 | <1% | 14 | $337.00 | |
| 90681 | <1% | 117 | $328.69 | |
| 84445 | <1% | 13 | $327.60 | |
| 82465 | <1% | 28 | $325.00 | |
| 82530 | <1% | 15 | $267.12 | |
| 82157 | <1% | 14 | $258.72 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 137 | $235.20 |
| 80051 | <1% | 13 | $231.00 | |
| 82705 | <1% | 25 | $214.20 | |
| 84681 | <1% | 13 | $211.68 | |
| 90723 | <1% | 324 | $198.00 | |
| 83090 | <1% | 15 | $184.95 | |
| 82239 | <1% | 17 | $176.40 | |
| 86593 | <1% | 13 | $156.00 | |
| 90633 | <1% | 366 | $103.92 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 7,273 | $53.89 |
| 99024 | <1% | 265 | $1.07 | |
| 90611 | <1% | 53 | $0.26 | |
| G8916 | Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic initiated on time | 0% | 528 | $0.00 |
| 90651 | 0% | 89 | $0.00 | |
| 99153 | Mod sedat endo service >5yrs | 0% | 26 | $0.00 |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer or hospital admission upon discharge from the facility | 0% | 2,768 | $0.00 |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 0% | 2,035 | $0.00 |
| 99152 | 0% | 58 | $0.00 | |
| 99337 | 0% | 12 | $0.00 | |
| 90700 | 0% | 12 | $0.00 | |
| 90734 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMCCULLER, TAMMY (REVENUE CYCLE)
| Provider | Location | Paid |
|---|---|---|
| Kaiser Foundation Health Plan of the Northwest | Portland, OR | $61.71M |
| Kaiser Foundation Hospitals | Hillsboro, OR | $4.56M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.